| Literature DB >> 22605857 |
Aizuri A Murad1, Maureen Connolly, Anne-Marie Tobin.
Abstract
Statins are widely prescribed medications and very well tolerated. Rosuvastatin is another member of this drug used to treat dyslipidaemia. It is a competitive inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase. Immunobullous disease is usually idiopathic but can be drug-induced. Both idiopathic and iatrogenic forms share common clinical and immunohistological features. The authors report a case of pemphigoid induced by rosuvastatin, a commonly prescribed medication. To our knowledge, there is limited report on rosuvastatin associated with pemphigoid in the literature.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22605857 PMCID: PMC3351646 DOI: 10.1136/bcr.11.2011.5180
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X